MedWatch

Novo sees lucrative opportunities and increased competition in China

A strong position on the Chinese market makes for a promising future for Novo Nordisk’s activities in the country, according to the company’s General Manager in China. However, the local and global field of competition is also growing.

Foto: Novo Nordisk / PR

Novo Nordisk’s future in China looks promising and challenging at the same time.

While the company benefits from a new sales strategy and Victoza’s inclusion on the national reimbursement list, increased competition from local as well as global actors is brewing.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier